| 000 | 01356 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513205857.0 | ||
| 264 | 0 | _c20000605 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0022-3417 | ||
| 024 | 7 |
_a10.1002/(SICI)1096-9896(200005)191:1<86::AID-PATH573>3.0.CO;2-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Brien, B A | |
| 245 | 0 | 0 |
_aNicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis. _h[electronic resource] |
| 260 |
_bThe Journal of pathology _cMay 2000 |
||
| 300 |
_a86-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCyclophosphamide |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xchemically induced |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xchemically induced |
| 650 | 0 | 4 |
_aIslets of Langerhans _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 |
_aNiacinamide _xtherapeutic use |
| 700 | 1 | _aHarmon, B V | |
| 700 | 1 | _aCameron, D P | |
| 700 | 1 | _aAllan, D J | |
| 773 | 0 |
_tThe Journal of pathology _gvol. 191 _gno. 1 _gp. 86-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/(SICI)1096-9896(200005)191:1<86::AID-PATH573>3.0.CO;2-0 _zAvailable from publisher's website |
| 999 |
_c10720879 _d10720879 |
||